IT systems · Practical guide

Validating TrackWise Digital: from quality event to effectiveness assessment

In TrackWise Digital, which event starts an action, who needs training after a document change and when may an effectiveness check close? Tie the answers to the configuration your team uses. The worked example distinguishes Salesforce, QuickTrack and Quality Process Accelerators and tests handovers, deadlines and missing evidence.

Table of contents

At a glance

How do you validate TrackWise Digital for your GMP process?

Define the boundary between TrackWise Digital, the QPA package, the configuration, interfaces and the Salesforce platform. Trace a quality workflow through responsible roles, linked records and business closure criteria. Use relevant supplier evidence and test gaps against independently defined outcomes. Check document and training versions, reasons for deadline changes, and the distinction between a completed action and demonstrated effectiveness.

  • Digital, classic TrackWise, and TrackWise Manufacturing have different product scopes.
  • Assess QPA and QuickTrack against the package and configuration actually offered.
  • Completed training, completed action, and effective CAPA are distinct statements.
  • Verify complete relationships and justified decisions, not just visible status colors.

Distinguish digital, Salesforce, and QuickTrack appropriately

Honeywell offers TrackWise Digital as a cloud-based QMS. The technical product page specifies Salesforce PaaS and the Lightning interface. The traditional TrackWise QMS is listed separately in the portfolio as an on-premises solution; TrackWise Manufacturing includes a dedicated production module. Therefore, the MES- or batch execution functions within this module do not constitute part of the Digital Project solely due to the shared product name.

QuickTrack is positioned for startups and smaller to mid-sized enterprises. Review the specific offering: included processes, user roles, documents, training features, interfaces, and support. A target audience description does not confirm whether your site workflow fits within the package. Maintain version and agreed-upon scope based on your contract, actual delivery, and associated release documentation.

This guide addresses quality-related processes in the manufacture of human medicinal products. EU GMP Annex 11 serves as a framework for computerized systems. Other applications require individual assessment. FDA Part 11 is relevant based on applicable recordkeeping requirements and actual electronic use; a QMS software name does not constitute universal FDA or medical device regulatory obligation.

Sources: [1] [2] [4] [5] [6] [11]

Further reading:

Evaluate the QPA package as a concrete starting point

Quality Process Accelerators are predefined quality processes. A supplier contribution dated 8 April 2021 describes, among other things, linkages between CAPA, changes, training, and effectiveness testing, as well as a request for extension of deadlines. This historical contribution outlines the approach; it does not confirm the current deliverables or the setup of your client. Request appropriate package versions, process descriptions, change records, and actual test documentation.

Assign each required procedure to the provided standard, a local adaptation, or an interface. The manufacturer designation "pre-validated" alone does not imply either the scope of validation or its transferability. Relevant external evidence may also cover pertinent process functions. Critical factors are configuration, testing environment, acceptance criteria, and results, not the general origin of the document.

Define the remaining questions prior to test execution. Example: Does the package cover assignment of training, but does your site additionally require a decision on appropriate employee selection? Then carefully evaluate this gap and its implications. An additional local mandatory rule may necessitate new negative tests, even though the underlying standard has already been assessed.

Sources: [3] [1] [6]

A complete quality chain shall be defined as part of testing.

The following example is an internal work aid and does not represent a completed TrackWise test. In the example event QE-17, a documented cross-check is missing during the preparation of a material container. The investigation leads to CAPA-17 and to the refinement of instruction SOP-08 from version 3 to version 4. Training is hereby considered an integral part of the corrective action; it is not universally accepted as a solution for all deviations.

The test concerns twelve named employees. The action is due by day 20. Its effectiveness is then assessed over the next twenty suitable transactions. The predefined example criterion is no recurrence of the same error. Twenty is a test assumption here. A real process would need a reason for choosing that sample size.

Example: Process and analytical matrix for QE-17 / CAPA-17
StepLinking and Starting PointResponsibility assignmentComplete as required
Investigate the event QE-17 → CAPA-17; Findings and affected process described Investigation responsible party documents the investigation The action has a traceable link to the root cause identified; a mere training assignment is insufficient.
Change instruction Change CH-08 → SOP-08, Version 4; previously Version 3 Authorised document responsible party decides on issuance Release and efficacy of version 4 are traceable; version 3 remains historically assignable.
Conduct training TR-17 → SOP-08 version 4, twelve affected employees Training responsible party verifies assignment and completion Twelve appropriate closures refer to version 4; ten closures or version 3 do not meet test specifications.
Change date ER-17 → CAPA-17; request submitted on day 20, to be addressed by day 30 Authorized decision-maker evaluates the initial and intermediate controls The request remains distinguishable from the approved date; the original date and rationale are clearly justifiable.
Efficacy determines EV-17 → CAPA-17; twenty processes following implementation A qualified evaluator assesses the results Upon repetition, the example criterion is not met; further decisions and actions are documented.

Sources: [3] [7] [8] [6]

Check training adequacy, not just completion rates

The current digital product page references document and training management. However, for CAPA-17, a more precise relationship is required: which document version was effective, for which activities is it relevant, and what evidence is associated with which employee? A green training status without version reference does not adequately address these questions.

Prepare two targeted failure scenarios: One employee is trained only up to Version 3; the other holds a qualification for Version 4 but does not belong to the required group. The resulting qualification rate may still appear plausible. Therefore, always verify identities and employment relationships prior to counting the twelve prescribed qualifications. For substitutes, new hires, and employees absent for an extended period, a clearly defined organizational procedure is required.

Chapter 2 of the GMP Guideline addresses task-specific training and its practical effectiveness. This does not imply a general obligation to implement a specific quiz function. Define an appropriate form of evidence. Training can be a mitigation action; whether the original error is subsequently controlled remains a separate professional judgment. This distinction should also be recognized by your data model.

Sources: [1] [8] [7] [6]

Further reading:

Extension of deadline and efficacy to be decided separately

In the example, two training completions are still missing on Day 18, due to the cancellation of the required practical session. ER-17 therefore requests Day 30 instead of Day 20. As a justified interim control, the example process specifies that the two untrained employees shall not perform the affected task. Whether such a solution is technically valid would need to be assessed in a real-world process context.

The expected behavior is: The request shall not alter the effective date without the predefined decision. Upon approval, Day 20 shall remain visible as the original scheduled date; Day 30, reason, decision-maker, and decision timestamp shall be added. An updated date field lacking this contextual linkage would be insufficient for the intended evaluation. The actual technical implementation must be substantiated based on your configuration.

Twelve completed training sessions on Day 28 in the example still do not permit a positive efficacy conclusion. If, during the subsequent observation period, nineteen correct events and one repetition are identified, the predefined criterion is not met. The evaluator reviews the implications; a specific automatic re-opening is not asserted. Clinical and technical workflow statuses must remain consistent.

Sources: [3] [7] [9] [6]

Perform targeted challenge samples for the configured procedure flow.

Use a documented initial state and restore it prior to independent variants. Otherwise, a previously authorized extension or already archived evaluation may mask a failure scenario. Record, for each instance, the package and configuration status, roles used, and associated keys. The following matrix outlines planned expectations, not any committed digital standard functions.

After each run, compare both the visible condition and the required records. An rejected conclusion must not appear as completed in the report. Conversely, a system error alone does not prove that no unauthorized change was recorded.

Example: Control samples with unambiguous target value
Test inputExpected process outcomeEvidence in the test batch
Ten of twelve appropriate training sessions completed Condition not fully met CAPA-17 does not receive an inappropriate closure; two missing personnel remain evident.
Twelve closures, one of which is only for SOP-08 Version 3 Target version not fully covered The incorrect document reference is detected; no purely numerical success statement.
ER-17 requests review on Day 30; decision is pending Day 20 remains the agreed-upon date. The application and current deadline are distinguishable; the report shows no approved extension.
Authorized extension by authorized role Day 30 applies with documented decision Day 20, Root cause, decision maker, and timing remain traceable.
EV-17 includes 19 relevant processes and 1 repetition Effectiveness criterion not met No false positive assessment. The subsequent decision and its basis can be traced.
EV-17 is incorrectly linked to CAPA-71 Evidence belongs to the wrong case False reference is prevented or detected through the predefined control pathway; CAPA-17 remains without valid evaluation.

Sources: [6] [7] [8] [10]

Designing powers, consents and history appropriate

Define roles by the decisions each person can make. Someone who carries out a corrective action does not automatically have authority to assess its effectiveness. Technical administrator rights do not confer authority to close the action on behalf of the process owner. The organisation and process determine which tasks people may combine and where independence is needed. This does not establish a universal two-person rule for every click.

Review relevant changes to assignment, schedule, document version, and assessment. Define who is responsible for reviewing this history and for what purpose. The scope of audit trails and review cannot be inferred from the Salesforce platform or any visible change log. Public product pages do not substitute for version-appropriate documentation and configuration verification.

A status change may represent a technical redirect, a professional approval, or an electronic signature. Define the meaning and verify the actual implementation. The required records shall preserve the decision context throughout their specified retention period. A single PDF excerpt is only sufficient if it retains the necessary content and context.

Sources: [6] [9] [11]

Separate application, platform, and associated data

The supplier portal describes API-driven connections to other enterprise systems. This does not constitute a specification for your training, personnel, or ERP system integration. For each data transfer, clearly document who is responsible for the information, the identifier used to identify it, and the status being transmitted. Receipt of a message and a professionally valid mapping are distinct outcomes.

For TR-17, it would be necessary to verify whether an external closing notification addresses the correct individual, SOP version, and training activity. In the planned test, send a delayed or duplicate notification. Prioritize defining how such cases should be handled and how incomplete transfers should be visible. No specific digital API or existing automated duplicate detection mechanism is required.

Assess platform changes, application release, QPA modification, and local configuration jointly based on their impacts. A Salesforce record may cover relevant platform aspects, but does not automatically establish the technical CAPA-17 chain. Additionally, clarify who is responsible for incidents, backups, recovery, and required exports, and which documents the contract actually makes available.

Sources: [2] [6] [10]

Further reading:

For SMEs, clarify effort and involvement prior to project initiation

Begin with a representative quality process rather than a comprehensive wishlist of features. The process owner explains root cause analysis and closure logic; relevant functional areas provide document and training guidelines, while IT outlines the platform and handover responsibilities. Quality assurance and decision-makers evaluate the evidence of validation based on their established authorities. The supplier describes the package and deviations from it.

Effort arises particularly due to multiple locations, differing role models, accumulated data, independent closure rules, and external training systems. QuickTrack could serve as a suitable starting point if the specific package aligns with your needs. However, publicly available manufacturer information does not provide reliable project timelines nor a general price or suitability assurance for your SME.

Arrange a feasible approach to release and deviation management prior to usage. Following changes, targeted re-runs of the affected chain are recommended; not every technical correction necessitates a full initial test. Periodic assessments should capture actual deviations, modifications, and new usages. Open gaps in validation evidence remain visible to the responsible party and their impact until a decision is made.

Sources: [1] [6] [10]

Checklist for a verifiable digital process chain

A test release becomes more credible when the desired behavior is predefined. Use this list for initial alignment and supplement it with the specific characteristics of your particular package. It serves as a working aid, not a regulatorily prescribed document structure.

  • Digital application, QPA/configuration status, Salesforce linkage and scope of agreement defined.
  • QuickTrack suitability assessed based on actual processes rather than company size.
  • Event, action, change, training, and effectiveness decision clearly linked.
  • Affected individuals and required documentation professionally defined.
  • Execution and efficacy described with separate, justified conditions.
  • Original deadline, extension request, and approved deadline are distinguishable.
  • Authorities, relevant history, and required retention clarified.
  • Interface errors, incorrect relationships, and premature test closure as test preparation.
  • Supplier documentation assigned and remaining local gaps justified.
  • Release assessment, failure pathway, and internal oversight with designated responsible parties agreed.

Sources: [6] [7] [8] [10]

Project experience and collaboration

Link CAPA decisions to the effectiveness check in the workflow

With process owners, we select a TrackWise Digital quality transaction from receipt to closure. We examine which decision triggers a status change and where actions, evidence and effectiveness assessment come together. This can support focused revision of an existing CAPA workflow. For several new quality processes, we agree an implementation sequence and clear handovers with your team.

Frequently asked questions about TrackWise Digital

Is TrackWise Digital the same as classic TrackWise?

No. Honeywell offers Digital as a cloud-based QMS on Salesforce and the traditional TrackWise QMS as a separate on-premises product. TrackWise Manufacturing is also a distinct module. Therefore, evaluate products, components, and offerings based on their actual designations. A web address containing "trackwise" or a mixed-product page is insufficient to accurately assign features of your application.

Sources: [4] [2]

Does QuickTrack replace validation for a small company?

No. The positioning for smaller companies describes an offered entry point, not the exemption of the intended GMP process. Clarify which procedures and evidence are included and what adaptations are required. Appropriate documentation can help reduce effort. The specific usage, interfaces, and remaining gaps in evidence must still be clearly evaluated.

Sources: [1] [6]

What does a "pre-validated" QPA described for our project mean?

Show the actually reviewed package status and its results. Compare these against your requirements, roles, and changes. Appropriate documentation can be imported; deviations from the reviewed scope require a justified amendment. The QPA supplier contribution dates from 2021 and neither confirms a current package nor the release of your client.

Sources: [3] [6]

Is a completed training already valid evidence of CAPA?

It first proves the training qualification defined for this purpose. Whether a measure adequately masteres the error examined is another question. Pre-determine which observations are used to evaluate the effectiveness. In the example of this article, twelve appropriate training courses can be complete, while a subsequent repetition of the error fails the separate effectiveness criterion.

Sources: [7] [8]

How do we establish a testable effectiveness criterion for a CAPA?

Start with the investigated failure scenario and define where an effective corrective action becomes evident. Determine the scope, time period, acceptance threshold, and decision upon non-compliance prior to observation. Justify this selection based on root cause and risk. The twenty steps in the example of this article do not represent a minimum requirement. Then verify whether the software adequately supports the agreed evaluation pathway.

Sources: [7] [10]

How do we verify extension requests in TrackWise Digital?

Distinguish the request, current deadline and approved change. Check the rationale, authority to decide and link to the correct record. Test what the report shows before a decision. Demonstrate the control for the actual version and configuration. The historical QPA article does not establish the same setup in every current tenant.

Sources: [3] [9] [6]

Does validation of the Salesforce platform suffice?

It may be possible to demonstrate appropriate technical foundations, but this does not automatically validate the technical quality process. Key elements include digital applications, Quality Process Assurance (QPA), local rules, and integration interfaces. Assign existing evidence to its actual scope and, where necessary, review additional areas where customer-specific assignments or closure conditions fall outside the scope of current evidence.

Sources: [2] [6]

Is an approved workflow status automatically an electronic signature?

An approved workflow status alone does not constitute evidence of an electronic signature. What is critical is the action that generates the approval, who is authorized to perform it, and how the approval remains linked to the dataset. Evaluate this specific function within the applicable regulatory framework. Neither TrackWise Digital nor an electronic approval button individually triggers compliance with FDA Part 11.

Sources: [6] [11]

What tasks must we internally undertake?

You require professional judgment regarding root cause, corrective actions, training needs, and effectiveness, as well as clear authorities. The IT department or designated partner shall explain system configuration and data flows. The supplier shall provide package information and available evidence. Even in a small team, these responsibilities must be clearly assigned; a specific number of personnel or universal signature sequence is not required.

Sources: [6] [7]

What determines the effort following a digital update?

Evaluate altered functions, QPA rules, platform dependencies, and custom interfaces in relation to the affected quality decisions. Leverage release documentation and relevant existing tests. A changed training scope may necessitate a targeted CAPA chain validation; a different change may require alternative forms of evidence. Generic full re-execution or complete test waiver cannot be justified solely on the term "Update".

Sources: [6] [10]

Sources and review date

Date: 6 October 2026. Current public product pages do not provide a numerical digital version. The QPA contribution from 2021 serves as a historical functional context; the current package scope and customer configuration must be separately defined. Tables and case identifiers are standalone audit aids and do not represent completed product testing. Focus: Human medicinal product GMP.

  1. TrackWise Digital
  2. TrackWise Digital Technology Platform
  3. Simplify and Standardize: The Power of Quality Process Accelerators
  4. Explore TrackWise – Product Ecosystem
  5. European Commission: EudraLex Volume 4
  6. European Commission: EU GMP Annex 11 – Computerised Systems
  7. European Commission: EU GMP Chapter 1 – Pharmaceutical Quality System
  8. European Commission: EU GMP Chapter 2 – Personnel
  9. European Commission: EU GMP Chapter 4 – Documentation
  10. EMA: ICH Q9(R1) – Quality Risk Management, Step 5, Corr.2
  11. FDA: Part 11, Electronic Records; Electronic Signatures – Scope and Application

Sources checked: .

Daniel Herrmann, Daniel Herrmann Consulting

Daniel Herrmann Consulting

Make the quality chain specifically verifiable

We support you in integrating package content, local regulations, and existing evidence to derive targeted inspection cases for your quality decisions.

  • Computer system validation →

    Bring your GxP systems into validated operation, from laboratory software, MES and eQMS to ERP. We define the scope, plan risk-based tests using GAMP 5 and hand the evidence to QA for release.

Send a project enquiry Customer testimonials →